Career Opportunities

…

Galecto, Inc is a biotech company with offices in Copenhagen, Boston, London, Montreal, Gothenburg, and Edinburgh. Galecto, Inc develops small molecule based therapeutics for the treatment of severe diseases, focusing on fibrosis and cancer. Our most advanced program is in clinical Phase IIB for the treatment of Idiopathic Pulmonary Fibrosis.

We encourage anyone interested in a job to apply, irrespective of gender, age, race, religion, or ethnicity.

Galecto, Inc. develops small molecules for the treatment of severe diseases, including fibrosis and cancer. The company, founded in 2011, builds on more than 10 years of research centering on the role of galectin-3 and LOXL-2, and the use of modulators of these proteins to treat fibrosis-related diseases and cancer. Combined with a strong patent estate, these assets give Galecto a unique therapeutic platform.

Follow us

Board
Management
Founders